ACN - Company News

Press Releases


Saturday, September 27, 2014

에스페리테, 중간엽 줄기세포로 뇌성마비 치료제 개발 계획
유럽의 줄기세포 냉동보존 부문 선도기업으로 최근 예측의학 및 변행재생의학 R&D 부문에 진출 중인 에스페리테(Esperite)가 자사 연구개발 부문 계열사인 더 셀 팩토리(The Cell Factory)를 통해 자체 기술을 이용한 임상실험용 자가 중간엽 줄기세포(MSCs) 생산에 나선다. more info >>

Esperite社R&D部門「セルファクトリー」がGMP準拠の幹細胞生物生産技術を導入、第1弾は脳性麻痺の臨床試験を目標
欧州で幹細胞の凍結保存の分野において業界をリードするEsperite（Euronext: ESP）は現在、予防医学およびトランスレーショナル再生医療のR&D領域に参入しており、同社事業部門の「The Cell Factory（セルファクトリー）」にて、自家間葉系幹細胞の臨床グレードの生産で、独自の新技術を導入します。 more info >>

Esperite 的研發部“細胞工廠”實施 GMP 幹細胞生物生產技術並將腦性麻痺作為首批臨床試驗目標
Esperite（泛歐證交所：ESP），歐洲幹細胞低溫貯藏的領導者現在進入預測醫學和移植再生研發領域，在其業務單位“細胞工廠”中為自體間葉細胞和基質乾細胞的臨床級生產實施自己的專屬全新技術。 more info >>

Esperite 的研发部“细胞工厂”实施 GMP 干细胞生物生产技术并将脑性麻痹作为首批临床试验目标
Esperite（泛欧证交所：ESP），欧洲干细胞低温贮藏的领导者现在进入预测医学和移植再生研发领域，在其业务单位“细胞工厂”中为自体间叶细胞和基质干细胞的临床级生产实施自己的专属全新技术。 more info >>

Thursday, September 25, 2014

Esperite's R&D Division "The Cell Factory" implements GMP Stem Cell Bioproduction Technology and aims the Cerebral Palsy as first clinical trial
Esperite (Euronext: ESP), the European leader in stem cells cryopreservation now entering the fields of predictive medicine and translational regenerative medicine R&D, implements its own proprietary new technology for clinical grade production of autologous mesenchymal and stromal stem cells in its business unit The Cell Factory. more info >>


1

Latest Press Releases

Masverse Unveils Groundbreaking Blockchain Platform Apr 27, 2024 02:40 HKT/SGT

Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans Apr 26, 2024 23:00 HKT/SGT

Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family Apr 26, 2024 22:25 HKT/SGT

FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences Apr 26, 2024 21:10 HKT/SGT

汇聚科技有限公司公布截至二零二三年十二月三十一日止末期业绩 Apr 26, 2024 18:53 HKT/SGT

匯聚科技有限公司公佈截至二零二三年十二月三十一日止末期業績 Apr 26, 2024 18:43 HKT/SGT

UK advertising reports GBP36.6bn spend in 2023 Apr 26, 2024 18:30: JST

TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023 Apr 26, 2024 18:26 HKT/SGT

UK advertising reports GBP36.6bn spend in 2023 Apr 26, 2024 17:30 HKT/SGT

CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine Apr 26, 2024 15:36 HKT/SGT

可持续发展三大支柱引领海通恒信ESG必答卷高分亮相 Apr 26, 2024 15:28 HKT/SGT

可持續發展三大支柱引領海通恆信ESG必答卷高分亮相 Apr 26, 2024 15:25 HKT/SGT

Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project Apr 26, 2024 14:34: JST

スパークス・グループによる「宇宙フロンティア2号ファンド」の設立について Apr 26, 2024 14:00: JST

中滙集團公佈2024財年中期業績 Apr 26, 2024 13:51 HKT/SGT


More News >>


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575